Trojano M - Search Results

1

Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score.

Mallucci G, Ferraro OE, Trojano M, Amato MP, Scalfari A, Zaffaroni M, Colombo E, Rigoni E, Iaffaldano P, Portaccio E, Saraceno L, Paolicelli D, Razzolini L, Montomoli C, Bergamaschi R. Mallucci G, et al. Among authors: trojano m. J Neurol. 2024 Jun;271(6):3496-3505. doi: 10.1007/s00415-024-12304-5. Epub 2024 Mar 26. J Neurol. 2024. PMID: 38532143

2

Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events.

Trojano M, Avolio C, Manzari C, Calò A, De Robertis F, Serio G, Livrea P. Trojano M, et al. J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):300-6. doi: 10.1136/jnnp.58.3.300. J Neurol Neurosurg Psychiatry. 1995. PMID: 7897410 Free PMC article.

3

Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.

Trojano M, Avolio C, Simone IL, Defazio G, Manzari C, De Robertis F, Calò A, Livrea P. Trojano M, et al. Neurology. 1996 Dec;47(6):1535-41. doi: 10.1212/wnl.47.6.1535. Neurology. 1996. PMID: 8960741

4

Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system.

Trojano M, Avolio C, Ruggieri M, De Robertis F, Giuliani F, Paolicelli D, Livrea P. Trojano M, et al. Mult Scler. 1998 Feb;4(1):39-44. doi: 10.1177/135245859800400110. Mult Scler. 1998. PMID: 9532592

5

Serum soluble intercellular adhesion molecule-I in MS: relation to clinical and Gd-MRI activity and to rIFN beta-Ib treatment.

Trojano M, Avolio C, Ruggieri M, Defazio G, Giuliani F, Paolicelli D, Livrea P. Trojano M, et al. Mult Scler. 1998 Jun;4(3):183-7. doi: 10.1177/135245859800400318. Mult Scler. 1998. PMID: 9762671 Clinical Trial.

6

Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS.

Trojano M, Avolio C, Liuzzi GM, Ruggieri M, Defazio G, Liguori M, Santacroce MP, Paolicelli D, Giuliani F, Riccio P, Livrea P. Trojano M, et al. Neurology. 1999 Oct 22;53(7):1402-8. doi: 10.1212/wnl.53.7.1402. Neurology. 1999. PMID: 10534242

7

Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells.

Trojano M, Defazio G, Avolio C, Paolicelli D, Giuliani F, Giorelli M, Livrea P. Trojano M, et al. J Neurovirol. 2000 May;6 Suppl 2:S47-51. J Neurovirol. 2000. PMID: 10871785 Clinical Trial.

8

The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes.

Trojano M, Paolicelli D. Trojano M, et al. Neurol Sci. 2001 Nov;22 Suppl 2:S98-102. doi: 10.1007/s100720100044. Neurol Sci. 2001. PMID: 11794488 Review.

9

The transition from relapsing-remitting MS to irreversible disability: clinical evaluation.

Trojano M, Paolicelli D, Bellacosa A, Cataldo S. Trojano M, et al. Neurol Sci. 2003 Dec;24 Suppl 5:S268-70. doi: 10.1007/s10072-003-0171-6. Neurol Sci. 2003. PMID: 14652786 Review.

10

The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study.

Solaro C, Brichetto G, Amato MP, Cocco E, Colombo B, D'Aleo G, Gasperini C, Ghezzi A, Martinelli V, Milanese C, Patti F, Trojano M, Verdun E, Mancardi GL; PaIMS Study Group. Solaro C, et al. Among authors: trojano m. Neurology. 2004 Sep 14;63(5):919-21. doi: 10.1212/01.wnl.0000137047.85868.d6. Neurology. 2004. PMID: 15365151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

462 results

Search Page